Celgene Corp. | Balance Sheet
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,687
7,547
6,961
8,331
12,056
6,042
Total Accounts Receivable
1,061
1,167
1,421
1,664
2,001
2,215
Inventories
340
393
443
498
541
458
Other Current Assets
462
606
576
375
294
352
Total Current Assets
7,551
9,713
9,401
10,868
14,892
9,067
Net Property, Plant & Equipment
593
643
814
930
1,070
1,367
Intangible Assets
4,881
6,259
15,737
15,258
13,302
24,216
Other Assets
353
685
947
893
877
755
Total Assets
13,378
17,340
26,964
28,086
30,141
35,480
ST Debt & Current Portion LT Debt
545
606
-
501
-
Accounts Payable
156
198
241
247
305
Income Tax Payable
16
144
20
41
84
Other Current Liabilities
1,229
1,164
1,708
2,170
2,598
Total Current Liabilities
1,946
2,112
1,969
2,959
2,987
Long-Term Debt
4,197
6,266
14,161
13,789
15,838
Provision for Risks & Charges
284
1,381
1,412
1,443
80
Deferred Taxes
805
514
2,831
2,382
1,327
Other Liabilities
558
501
606
777
2,988
Total Liabilities
7,788
10,815
21,045
21,486
23,220
Common Equity (Total)
5,590
6,525
5,919
6,599
6,921
Total Shareholders' Equity
5,590
6,525
5,919
6,599
6,921
Total Equity
5,590
6,525
5,919
6,599
6,921
Liabilities & Shareholders' Equity
13,378
17,340
26,964
28,086
30,141
About Celgene
View Profile
